The incidence of diabetes mellitus and hepatocellular carcinoma (HCC) has been
increasing worldwide during the last few decades, in the context of an increasing prevalence …

The occurrence of hepatocellular carcinoma (HCC) is two to three times higher in patients
with diabetes mellitus (DM), the prevalence of which is increasing sharply worldwide. The …

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths
worldwide. HCC develops mainly on a background of chronic liver disease, with an …

The Influence of Diabetes in the Pathogenesis and the Clinical Course of Hepatocellular
Carcinoma: Recent Findings and New Persp Page 1 Send Orders for Reprints to reprints@benthamscience.net …

Hepatocellular carcinoma (HCC) is a grave complication of cirrhosis. In the United States,
the age-adjusted incidence of HCC has recently more than doubled, increasing from 1.4 per …

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
in the world. NAFLD is a hepatic manifestation of insulin resistance, the core …

Type 2 diabetes (T2D) is a risk factor for hepatocellular carcinoma (HCC). However, it is
unknown whether T2D duration or additional metabolic comorbidities further contribute to …

Hepatocellular carcinoma (HCC), a disease with poor survival rates unless recognized and
treated early, ranks as the fifth most common cancer worldwide and has a rising incidence in …

Abstract Purpose of Review This review aims to assess the epidemiological evidence for a
link between type 2 diabetes and hepatocellular carcinoma and to investigate possible …

Background The impact of pre-existing diabetes mellitus (DM) on hepatocellular carcinoma
(HCC) occurrence and prognosis is complex and unclear. The aim of this meta-analysis is to …